DJ US Medical Devices Ishares (IHI) 124.79 $IHI Warning:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
DJ US Medical Devices Ishares (IHI) 124.79 $IHI

Warning: Top Healthcare Performers Now Overvalued
Wall Street Daily - at Seeking Alpha - Mon Jun 15, 10:48AM CDT
By Chris Worthington Over the past five years, one sector has outperformed all others in the S&P 500: healthcare. Biotech stocks have led the way, with the Nasdaq Biotechnology Index climbing a whopping 520% since early 2009. The...
BBP: 36.17 (+0.69), THQ: 20.01 (+0.17), HQL: 29.31 (+1.26), RXL: 77.11 (+2.58), XBI: 257.61 (+5.83), IBB: 382.39 (+8.81), LABU: 49.33 (+3.10), IHE: 181.45 (+2.56), IHF: 138.47 (+1.11), XHE: 96.39 (+0.47), BBC: 36.62 (+0.44), PPH: 73.84 (+0.65), PTH: 65.17 (+1.22), BBH: 139.04 (+3.03), FHLC: 36.84 (+0.53), IHI: 124.79 (+1.20), CURE: 41.30 (+1.88), VHT: 142.73 (+2.13), FXH: 68.86 (+0.74), RYH: 162.10 (+1.70), PBE: 59.82 (+1.30), IYH: 161.78 (+2.56), FBT: 126.44 (+2.59), XHS: 129.14 (+1.19), XPH: 131.41 (+1.16), XLV: 76.00 (+1.22), SBIO: 38.41 (+0.79), PSCH: 72.81 (+0.39), PJP: 81.43 (+1.22), MRK: 57.23 (+0.24), RXD: 46.87 (unch), HQH: 35.59 (+1.01), LABD: 28.29 (-2.08)

BUYINS.NET: EET, IHI, SNCR, FXA, UDN, AAXJ Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Jun 10, 7:18AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares Ultra MSCI Emerging Markets (NYSE:EET), iShares Dow Jones US Medical Devices Index Fund (NYSE:IHI), SYNCHRONOSS TECHNOLOGIES, INC. (NASDAQ:SNCR), CurrencyShares Australian Dollar Trust (NYSE:FXA), Powershares Db Us $ Index (NYSE:UDN), iShares MSCI All Country Asia ex Japan Index Fund (NASDAQ:AAXJ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
AAXJ: 59.10 (+0.70), SNCR: 43.99 (+0.27), FXA: 73.38 (+0.55), EET: 58.37 (+1.36), UDN: 21.88 (-0.05), IHI: 124.79 (+1.20)

Is The Healthcare Sector Rolling Over?
Matt Erickson - Seeking Alpha - Wed Apr 29, 7:04AM CDT
In a number of our previously published articles (including The Beginning Of The End , as well as in Choosing The Right Healthcare ETF ) we have made mention of the relatively dramatic outperformance we have seen in the healthcare sector year to...
RYH: 162.10 (+1.70), IHF: 138.47 (+1.11), PJP: 81.43 (+1.22), IBB: 382.39 (+8.81), IHI: 124.79 (+1.20), FXH: 68.86 (+0.74), XLV: 76.00 (+1.22)

BUYINS.NET: FLM, IPN, JO, KOL, PBP, IHI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Apr 16, 7:17AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of First Trust Ise Global Engineering And Construction Index Fu (NYSE:FLM), SPDR S&P International Industrial Sector ETF (NYSE:IPN), IPATH DJ-UBS COFFEE SUBINDEX (NYSE:JO), Market Vectors Coal ETF (NYSE:KOL), PowerShares S&P 500 BuyWrite Portfolio (NYSEBP), iShares Dow Jones US Medical Devices Index Fund (NYSE:IHI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
JO: 20.04 (+0.08), FLM: 46.86 (+0.70), KOL: 9.68 (+0.27), IHI: 124.79 (+1.20), PBP: 21.47 (+0.26), IPN: 29.54 (+0.03)

Government to raise Medicare Advantage rates, not cut them
Seeking Alpha - at Seeking Alpha - Tue Apr 07, 6:14AM CDT

RYH: 162.10 (+1.70), IYH: 161.78 (+2.56), RXL: 77.11 (+2.58), XHS: 129.14 (+1.19), UNH: 121.09 (+3.21), MO: 54.84 (+0.89), AET: 111.14 (+0.91), HNT: 66.09 (+0.49), HUM: 184.43 (+0.52), XLV: 76.00 (+1.22), IHF: 138.47 (+1.11), XHE: 96.39 (+0.47), PSCH: 72.81 (+0.39), PTH: 65.17 (+1.22), RXD: 46.87 (unch), IHI: 124.79 (+1.20), VHT: 142.73 (+2.13), FXH: 68.86 (+0.74)

12 Best Biotech and Health Care ETFs to Add to Your Portfolio
at The Street - Thu Mar 12, 9:49AM CDT
Biotech and health care are two of the hottest sectors in which to invest. TheStreet compiled a list of the best-rated ETFs tracking the two sectors.
IHE: 181.45 (+2.56), IHF: 138.47 (+1.11), XHE: 96.39 (+0.47), IYH: 161.78 (+2.56), XHS: 129.14 (+1.19), GRX: 11.30 (+0.20), FHLC: 36.84 (+0.53), IHI: 124.79 (+1.20), IXJ: 111.91 (+1.61), VHT: 142.73 (+2.13), FXH: 68.86 (+0.74), XLV: 76.00 (+1.22)

Notable ETF Outflow Detected - IHI, MDT, ABT, TMO
ETFChannel.com - Wed Feb 11, 9:52AM CST
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares US Medical Devices ETF where we have detected an approximate $80.8 million dollar outflow -- that's a 10.5%...
IHI: 124.79 (+1.20)

Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 36.17 (+0.69), RXL: 77.11 (+2.58), XBI: 257.61 (+5.83), IHE: 181.45 (+2.56), IHF: 138.47 (+1.11), PPH: 73.84 (+0.65), XHE: 96.39 (+0.47), BBC: 36.62 (+0.44), PTH: 65.17 (+1.22), BBH: 139.04 (+3.03), FHLC: 36.84 (+0.53), IHI: 124.79 (+1.20), CURE: 41.30 (+1.88), FXH: 68.86 (+0.74), VHT: 142.73 (+2.13), RYH: 162.10 (+1.70), PBE: 59.82 (+1.30), IYH: 161.78 (+2.56), FBT: 126.44 (+2.59), XHS: 129.14 (+1.19), XPH: 131.41 (+1.16), XLV: 76.00 (+1.22), SBIO: 38.41 (+0.79), PSCH: 72.81 (+0.39), PJP: 81.43 (+1.22), RXD: 46.87 (unch)

Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST

BBP: 36.17 (+0.69), RXL: 77.11 (+2.58), XBI: 257.61 (+5.83), IBB: 382.39 (+8.81), IHE: 181.45 (+2.56), IHF: 138.47 (+1.11), BBC: 36.62 (+0.44), PPH: 73.84 (+0.65), XHE: 96.39 (+0.47), PTH: 65.17 (+1.22), BBH: 139.04 (+3.03), FHLC: 36.84 (+0.53), IHI: 124.79 (+1.20), CURE: 41.30 (+1.88), FXH: 68.86 (+0.74), VHT: 142.73 (+2.13), RYH: 162.10 (+1.70), PBE: 59.82 (+1.30), IYH: 161.78 (+2.56), FBT: 126.44 (+2.59), XHS: 129.14 (+1.19), XPH: 131.41 (+1.16), XLV: 76.00 (+1.22), SBIO: 38.41 (+0.79), PSCH: 72.81 (+0.39), PJP: 81.43 (+1.22), RXD: 46.87 (unch)

iShares U.S. Medical Devices ETF Experiences Big Outflow
ETFChannel.com - Tue Nov 18, 10:01AM CST
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares US Medical Devices ETF where we have detected an approximate $32.7 million dollar outflow -- that's a 4.2%...
IHI: 124.79 (+1.20)

3 Sector ETFs Cheering Mid-Term Republican Win - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Nov 10, 12:00PM CST
Though these sector ETFs have seen volatile trading over teh past week, they will benefit most once Republican gain full control over Congress in January.
ITA: 116.98 (+1.85), IHI: 124.79 (+1.20), XLE: 70.56 (+2.05)

ETFs Set To Move On GOP Victory
Benzinga - Seeking Alpha - Fri Nov 07, 10:16AM CST
By Matthew McCall The Republicans pulled off a historic night in the mid-term elections as they took over the Senate and won several gubernatorial swing states. The Senate is the most important outcome of mid-term elections and it has several...
AMLP: 15.41 (+0.26), IHI: 124.79 (+1.20)

ETFs Slipping to Rank #5 this Earnings Season - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Oct 27, 1:00PM CDT
Given weak corporate earnings and huge levels of stock market volatility, several ETFs have slipped to Zacks ETF Rank of 5.
XTL: 56.02 (+0.49), BJK: 36.46 (+0.62), IHI: 124.79 (+1.20)

Stock Picking Grades For Health Care Sector Fund Managers
David Trainer - Seeking Alpha - Wed Oct 22, 8:30AM CDT
This report shows how well Health Care ETFs and mutual fund managers pick stocks. We juxtapose our Portfolio Management rating on funds, which grades managers based on the quality of the stocks they choose, with the number of good stocks available...
VRTX: 126.44 (+3.21), MDT: 77.48 (+1.82), XBI: 257.61 (+5.83), IHI: 124.79 (+1.20)

Medical Device ETF in Focus on Recent Merger Activity - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Oct 09, 7:02AM CDT
Recent deals on the merger and acquisition front puts the Medical Device ETF (IHI) in focus.
BDX: 149.25 (+2.92), MDT: 77.48 (+1.82), CFN: 59.91 (-0.06), COV: 106.71 (-1.36), IHI: 124.79 (+1.20)

Bet On This Top Ranked Medical Device ETF - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Aug 11, 5:07AM CDT
This top ranked ETF may be a good defensive bet in the current volatile market environment.
ABT: 50.98 (+0.29), XPH: 131.41 (+1.16), IHI: 124.79 (+1.20), XLV: 76.00 (+1.22)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 182

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 258

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 216

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 110

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 385

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 0

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading

Top 5 Most Recently Viewed Articles

Omni-Lite Industries Reports Impressive Fiscal Q3 Results

Updated Category News Views 143

Highlights from Omni-Lite's Third Quarter Fiscal 2025 Outstanding Financial Performance Omni-Lite Industries Canada Inc. (TSXV: OML) recently reported its financial results for the third quarter of fiscal 2025, demonstrating notable growth and resilience. With revenue reaching approximately US$4.0 million, Omni-Lite saw a remarkable year-over-year increase of 7.0%...

Continue Reading
Assessing the Impact of UK Fiscal Policy on Housing Market Trends

Updated Category News Views 200

Understanding the Current UK Housing Market Dynamics The U.K. housing market is currently facing a notable slowdown, primarily driven by tax-related uncertainties associated with fiscal policies. As potential buyers adopt a more cautious stance, residential property transactions have seen a decline. This trend poses immediate risks for sectors linked to housing, including...

Continue Reading
Radford Racing School Unveils New Exciting Driving Adventures

Updated Category News Views 226

Exciting New Driving Experiences at Radford Racing School Recently, Radford Racing School, known as a leader in performance driving education, announced its latest offerings that promise to thrill automotive enthusiasts of all ages and skill levels. With the introduction of six new driving experiences, there's now something for everyone at their legendary racetrack....

Continue Reading
AppLovin CEO Sells $21.5 Million in Shares Amid Growth Momentum

Updated Category News Views 137

AppLovin CEO's Notable Stock Sale Recently, AppLovin Corp (NASDAQ: APP) made headlines with a significant financial event: CEO and Chairperson Arash Adam Foroughi sold over $21.5 million worth of company stock. According to the latest SEC filing, this noteworthy transaction occurred over just two days, with share prices varying from $98.08 to $112.33 during that time....

Continue Reading
Olverembatinib's Breakthrough Status Enhances Leukemia Treatment Options

Updated Category News Views 396

Olverembatinib Gains Breakthrough Therapy Designation Ascentage Pharma, a prominent global biopharmaceutical company, is making significant strides in the treatment of serious medical conditions. With its latest achievement, olverembatinib has secured a Breakthrough Therapy Designation in China for its use alongside low-intensity chemotherapy in newly-diagnosed patients...

Continue Reading